The Clorox Company (NYSE:CLX) Position Reduced by Cerity Partners LLC

Cerity Partners LLC trimmed its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 8.9% during the fourth quarter, HoldingsChannel reports. The fund owned 38,151 shares of the company’s stock after selling 3,712 shares during the quarter. Cerity Partners LLC’s holdings in Clorox were worth $5,440,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in CLX. American Century Companies Inc. boosted its stake in Clorox by 18.0% during the 1st quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock valued at $1,157,000 after acquiring an additional 1,269 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of Clorox by 6.8% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock worth $2,289,000 after buying an additional 1,044 shares during the last quarter. Cibc World Market Inc. lifted its position in shares of Clorox by 276.6% in the 1st quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock worth $1,295,000 after buying an additional 6,844 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Clorox by 0.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock worth $95,073,000 after buying an additional 5,145 shares during the last quarter. Finally, Blair William & Co. IL lifted its position in shares of Clorox by 81.1% in the 1st quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock worth $3,410,000 after buying an additional 10,981 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CLX shares. Barclays reduced their price target on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 10th. DA Davidson restated a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research report on Monday, February 5th. JPMorgan Chase & Co. raised their price target on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research report on Thursday, January 18th. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a report on Tuesday, March 26th. Finally, Citigroup dropped their price objective on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a report on Tuesday. Four analysts have rated the stock with a sell rating and twelve have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $148.50.

Check Out Our Latest Analysis on Clorox

Clorox Stock Up 1.4 %

Clorox stock opened at $142.44 on Wednesday. The stock has a market cap of $17.68 billion, a price-to-earnings ratio of 226.10, a PEG ratio of 2.21 and a beta of 0.43. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The company’s 50-day moving average price is $150.67 and its two-hundred day moving average price is $141.68. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $178.21.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, beating the consensus estimate of $1.08 by $1.08. The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. Clorox’s quarterly revenue was up 16.0% on a year-over-year basis. During the same quarter last year, the company earned $0.98 EPS. On average, analysts expect that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.37%. Clorox’s dividend payout ratio is currently 761.92%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.